Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san francisco blog main
5
×
clinical trials
boston blog main
boston top stories
cancer
fda
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
startups
bain capital
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
crispr therapeutics
detroit blog main
detroit top stories
eli lilly
european society for medical oncology
indiana blog main
indiana top stories
investing
loxo oncology
mirati therapeutics
national
nonalcoholic steatohepatitis
orbimed advisors
pfizer
president trump
seattle blog main
seattle top stories
What
biotech
5
×
drug
5
×
cancer
annual
attention
companies
days
ipo
leading
new
research
roundup
therapeutics
activity
ahead
alzheimer’s
ambien
american
asco
assessed
athena
attendees
bio
black
camp’s
cash
ceo
chicago
chief
city
clinic
clinical
combinations
communities
community’s
conference
countouriotis
diamond
dog
eluded
Language
unset
Current search:
drug
×
" san francisco blog main "
×
biotech
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
